Immune interferon (IFN) is the product of activated T cells and its multiple effects on many cell types are well documented (see for example review by O'Garra et al., 1988) . Biological tests of the antiviral activity of IFN-7 are too insensitive and variable to measure IFN-2: levels in biological fluids. Development of a highly sensitive specific immunoradiometric assay (IRMA) that detects 0.01 international units (IU) of IFN-), permitted us to measure the MulFN-~, levels in lung lavage samples taken from mice during the course of an influenza virus infection. Furthermore, we find that transfer of cloned influenza-specific T cells which leads to a more rapid clearance of virus from the lung results in an earlier appearance of MulFN-~, in the bronchial lavage samples in comparison with intranasal infection per se.
The IRMA we developed for MulFN-y is a solid phase two site sandwich immunoassay based on the assays for human interferon ~, (HulFN-~) developed by Secher (1981) and Chang et al. (1984) . We used rat anti-MulFN-~ monoclonal antibodies (MAbs) R4-6A2 (Spitalny & Havell, 1984) and AN-18 (Prat et al., 1984) . Antibody from ascitic fluid grown in athymic mice (nu/nu) was precipitated with ammonium sulphate. MAb R4-6A2 was purified by Protein A-Sepharose 4B chromatography, the IgG1 eluted at pH 6 and stored at -20 °C. R4-6A2 IgG1 was iodinated with carrier-free ~2 s I (Amersham) using the chloramine T method (Greenwood et al., 1963) and desalted on a Dowex 1-× 8 (C1) column in 0.2~ bovine serum albumin in phosphate-buffered saline (BSA-PBS) (2 x 107 c.p.m./~tg), Etched polystyrene beads (Northumbria Biologicals; 6 mm diam.) were left overnight at 4 °C in AN-18 Ig solution (200 ~tg protein/ml PBS). These beads were then washed four or five times with 0.5~ BSA-PBS, and stored at 4 °C. Serial dilutions (in 0-5~ BSA-PBS) of MulFN-~ (international standard or laboratory samples; 225 gl/tube) were transferred to Luckham LP4 tubes, after excess binding sites had been blocked with 5~ BSA-PBS for 1 h. One AN-18 MAbcoated bead (blotted dry on paper) was added per tube. After 18 h at 4 °C, the beads were washed three times with 3 ml 0.5~ BSA-PBS. ~zSI-R4-6A2 (2 × 105 c.p.m./225 ~tl 0.5~ BSA-PBS) was added to the beads for 4 h, followed by three washes with 0.5 ~ BSA-PBS, before counting in an LKB gamma counter.
The dose-response curve showed linearity over the range of 0.01 to 10 IU/ml using the international standard for MulFN-~ Gg02-901-533 (Fig. 1) ; the coefficient of variation was < 10~ between 0.075 and 9.0 IU/ml. This IRMA has a detection limit of 0-01 IU/ml (100 c.p.m. with A/X31 virus were killed with a lethal dose intraperitoneally of pentobarbitone and 1 ml of PBS was delivered into the lungs through a small incision in the trachea via 1.2 mm (outer diam.) Portex tubing with a bevelled tip, attached to a 18 gauge needle and 1 ml syringe. BAL samples were obtained by three successive insertions and withdrawals of the PBS and cell-free supernatants were stored at -70 °C (Cannon et al., 1988) . IFN-y content of pooled BAL samples (three mice/group) at the times shown was assayed using the described IRMA. On completion of the BAL procedure, lungs were removed and homogenized for influenza virus titration in the allantoic cavities of 10-day-old chick embryos (Lin & Askonas, 1981) . Lung virus titre (O); lung lavage IFN-), titre (O).
at pH 2 for 18 h retained 3 to 4 % of its immunochemical activity, a result similar to that of Curry et al. (1987) . The IRMA was specific for MulFN-~, and did not detect HulFN-7, or mouse or human IFN-~/fl. We wished to apply this highly sensitive assay to try to assess the kinetics of MulFN-y release in bronchial lavage samples from lungs of influenza-infected mice. BALB/c mice were infected intranasally (i.n.) with A/X31 virus. Fig. 2 shows that lung virus titres peak on days 3 to 6, after which point there is rapid viral clearance. A sharp peak of MulFN-~, appears on day 6 postinfection, at a time when T cell-mediated cytotoxicity is detected in the lungs of infected mice (Yap & Ada, 1978) . The small amounts of MulFN-~ in bronchoalveolar lavage (BAL) samples (Cannon et al., 1988) are not detected by the conventional biological assays which are not very sensitive and also suffer from considerable variation between assays (Meager, 1987) .
Transfer of virus-specific cytotoxic T (Tc) cell clones into influenza-infected mice does not prevent infection but speeds up viral clearance and recovery. CD4 ÷ T helper (TH) clones or lines are much more variable in their effects on viral clearance , but CD4 ÷ line BAE5 is protective. Both cloned Tc and TH ceils have the ability to secrete IFN-~ on contact with specific antigen. Tc and TH cell clones or lines produce similar levels of IFN-7 in vitro (Table 1) . We wished to see whether we could detect earlier release of IFN-7 into BAL of T cell recipient mice infected with influenza virus. Day 4 was selected for sampling, because by day 6 there is a peak of IFN-7 from the host in response to the virus infection. Table 2 shows that low but reproducible and therefore significant release of IFN-7 is detected on day 4 in BAL following the transfer of Tc or TH lines or clones. Both the cloned Tc and Ta lines are effective in reducing (Taylor & Askonas, 1986; Thomas et al., 1986) were incubated at 5 x 105/ml in RPMI/10 for 24 h with appropriate antigen stimulation. For Tm this was u.v.-inactivated A/X31 (100 haemagglutination units/m|) or purified influenza nucleoprotein (1 ~tg/ml) and syngeneic, irradiated normal spleen cells as antigen-presenting cells (2 x 106/ml). For Tc, P815 ceils which had been infected with A/X31 virus for 90 min, then washed, Were used at 5 x 10S/ml. ~" IFN-7 in the supernatant was assayed by IRMA. (Taylor & Askonas, 1986) . Four or 6 days later, lungs were lavaged with 1 ml PBS.
5" The IFN-7 content of lung lavage samples from individual mice (four mice/group) was assayed using the described IRMA. lung virus titres by day 6, with slight reductions already occurring by day 4 ( Table 2 ). The T H line produces more IFN-~ than the Tc clone T5/5 and in fact this is reflected in the amounts of IFN-~, in BAL samples. The IFN-~ level in BAL samples is low, but reproducible in our experiments.
Thus we observe the appearance of IFN-~, in lung lavage samples 4 days after influenza infection following TH or Tc cell transfers which lead to earlier viral clearance, whereas IFN-? can only be detected by day 6 in BAL samples from control influenza-infected mice which start to clear the virus after day 6. There is a discrepancy between the low IFN-? titres found in BAL samples compared to the high amounts detected in a culture of 5 x 105 T cells/ml. This is not surprising since only a low proportion of the transferred cultured T cells reach the sites of infection because of migration problems (Dailey et al., 1982) , and IFN-~ in vivo has a very short half life. Furthermore, the volume of the BAL fluid will reflect the large dilution of what is probably highly localized IFN-? production by T cells in the lung tissues. Lukacher et al. (1984) also have shown specifically localized Tc activity that may not all be accessible to BAL, which only samples from superficial areas of the bronchoalveolar lung passages.
Our experiments demonstrate the high sensitivity of the IRMA for assaying low amounts of MulFN-~ in biological fluids to enable a study of kinetics of IFN-~ release in vivo. The effects we noted on the reduction of infectious influenza virus by transferred T cells may be due to the direct antiviral activity of IFN-~,, although this is not thought to be a major function of this particular species of IFN (e.g. Landolfo et al., 1988) . Interferons ~ and fl are known to be potent antiviral agents and IFN-a peaks in the lungs of influenza-infected mice on day 4 (Wyde et al., Short communication 1982) . A more likely explanation lies with the multiple immunoregulatory effects of IFN-y, but, in conjunction with the effector function of T ceils in the lungs of influenza-infected mice, its precise role remains to be explored further.
